Among MAFF binding partners, we observed that expression of NRF2, the most studied binding partner of small MAF proteins, was low in these breast cancer cell lines, suggesting that tumor invasion regulated by MAFF is NRF2 independent. The gene discussed is MAFF; the disease is breast cancer.